Severe cutaneous Candida infection during natalizumab therapy in multiple sclerosis

Neurology. 2010 Feb 9;74(6):521-3. doi: 10.1212/WNL.0b013e3181cef810.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Candida / physiology*
  • Female
  • Humans
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Retrospective Studies
  • Staphylococcal Skin Infections / etiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab